DeBerry Jennifer, Ness Timothy J, Robbins Meredith T, Randich Alan
Department of Psychology, University of Alabama at Birmingham, Birmingham, Alabama 35205, USA.
J Pain. 2007 Dec;8(12):914-23. doi: 10.1016/j.jpain.2007.06.011. Epub 2007 Aug 20.
Abdominal electromyographic (EMG) responses to noxious intensities of urinary bladder distention (UBD) are significantly enhanced 24 hours after zymosan-induced bladder inflammation in adult female rats. This inflammation-induced hypersensitivity is concomitantly inhibited by endogenous opioids because intraperitoneal (i.p.) naloxone administration before testing significantly increases EMG response magnitude to UBD. This inhibitory mechanism is not tonically active because naloxone does not alter EMG response magnitude to UBD in rats without inflammation. At the dose tested, naloxone does not affect bladder compliance in rats with or without inflammation. The effects of i.p. naloxone probably result from blockade of a spinal mechanism because intrathecal naloxone also significantly enhances EMG responses to UBD in rats with inflammation. Rats exposed to bladder inflammation from P90-P92 before reinflammation at P120 show similar hypersensitivity and concomitant opioid inhibition, with response magnitudes being no different from that produced by inflammation at P120 alone. In contrast, rats exposed to bladder inflammation from P14-P16 before reinflammation at P120 show markedly enhanced hypersensitivity and no evidence of concomitant opioid inhibition. These data indicate that bladder inflammation in adult rats induces bladder hypersensitivity that is inhibited by an endogenous opioidergic mechanism. This mechanism can be disrupted by neonatal bladder inflammation.
The present study observed that bladder hypersensitivity resulting from acute bladder inflammation is suppressed by an opioid-inhibitory mechanism. Experiencing bladder inflammation during the neonatal period can impair the expression of this opioid inhibitory mechanism in adulthood. This suggests that bladder insults during development may permanently alter visceral sensory systems and may represent 1 cause of painful bladder disorders.
成年雌性大鼠在酵母聚糖诱导的膀胱炎症发生24小时后,对膀胱膨胀(UBD)有害强度的腹部肌电图(EMG)反应显著增强。这种炎症诱导的超敏反应同时受到内源性阿片类物质的抑制,因为在测试前腹腔注射纳洛酮会显著增加对UBD的EMG反应幅度。这种抑制机制并非持续活跃,因为纳洛酮不会改变未发炎大鼠对UBD的EMG反应幅度。在所测试的剂量下,纳洛酮对有或无炎症的大鼠的膀胱顺应性均无影响。腹腔注射纳洛酮的作用可能是由于阻断了脊髓机制,因为鞘内注射纳洛酮也会显著增强炎症大鼠对UBD的EMG反应。在P120再次引发炎症之前,于P90 - P92暴露于膀胱炎症的大鼠表现出类似的超敏反应和伴随的阿片类物质抑制,反应幅度与仅在P120发生炎症时产生的反应幅度无差异。相比之下,在P120再次引发炎症之前,于P14 - P16暴露于膀胱炎症的大鼠表现出明显增强的超敏反应,且没有伴随阿片类物质抑制的证据。这些数据表明,成年大鼠的膀胱炎症会诱导膀胱超敏反应,该反应受到内源性阿片能机制的抑制。这种机制可被新生期膀胱炎症破坏。
本研究观察到急性膀胱炎症导致的膀胱超敏反应受到阿片类物质抑制机制的抑制。在新生儿期经历膀胱炎症会损害成年期这种阿片类物质抑制机制的表达。这表明发育过程中的膀胱损伤可能会永久性改变内脏感觉系统,并且可能是膀胱疼痛性疾病的一个原因。